76 related articles for article (PubMed ID: 22320445)
1. Doxorubicin-induced activation of NF-κB in melanoma cells is abrogated by inhibition of IKKβ, but not by a novel IKKα inhibitor.
Pletz N; Schön M; Ziegelbauer K; Emmert S; Liu N; Dobbelstein M; Schön MP
Exp Dermatol; 2012 Apr; 21(4):301-4. PubMed ID: 22320445
[TBL] [Abstract][Full Text] [Related]
2. KINK-1, a novel small-molecule inhibitor of IKKbeta, and the susceptibility of melanoma cells to antitumoral treatment.
Schön M; Wienrich BG; Kneitz S; Sennefelder H; Amschler K; Vöhringer V; Weber O; Stiewe T; Ziegelbauer K; Schön MP
J Natl Cancer Inst; 2008 Jun; 100(12):862-75. PubMed ID: 18544741
[TBL] [Abstract][Full Text] [Related]
3. NF-kappaB inhibition through proteasome inhibition or IKKbeta blockade increases the susceptibility of melanoma cells to cytostatic treatment through distinct pathways.
Amschler K; Schön MP; Pletz N; Wallbrecht K; Erpenbeck L; Schön M
J Invest Dermatol; 2010 Apr; 130(4):1073-86. PubMed ID: 19940859
[TBL] [Abstract][Full Text] [Related]
4. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation.
Tse AK; Wan CK; Shen XL; Yang M; Fong WF
Biochem Pharmacol; 2005 Nov; 70(10):1443-57. PubMed ID: 16181613
[TBL] [Abstract][Full Text] [Related]
5. Regulation and function of IKK and IKK-related kinases.
Häcker H; Karin M
Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
[TBL] [Abstract][Full Text] [Related]
6. Curcumin analog GO-Y030 is a novel inhibitor of IKKβ that suppresses NF-κB signaling and induces apoptosis.
Sato A; Kudo C; Yamakoshi H; Uehara Y; Ohori H; Ishioka C; Iwabuchi Y; Shibata H
Cancer Sci; 2011 May; 102(5):1045-51. PubMed ID: 21272158
[TBL] [Abstract][Full Text] [Related]
7. Magnolol suppresses NF-kappaB activation and NF-kappaB regulated gene expression through inhibition of IkappaB kinase activation.
Tse AK; Wan CK; Zhu GY; Shen XL; Cheung HY; Yang M; Fong WF
Mol Immunol; 2007 Apr; 44(10):2647-58. PubMed ID: 17240450
[TBL] [Abstract][Full Text] [Related]
8. Active roles for inhibitory kappaB kinases alpha and beta in nuclear factor-kappaB-mediated chemoresistance to doxorubicin.
Bednarski BK; Ding X; Coombe K; Baldwin AS; Kim HJ
Mol Cancer Ther; 2008 Jul; 7(7):1827-35. PubMed ID: 18644995
[TBL] [Abstract][Full Text] [Related]
9. IκB kinase-driven nuclear factor-κB activation in patients with asthma and chronic obstructive pulmonary disease.
Gagliardo R; Chanez P; Profita M; Bonanno A; Albano GD; Montalbano AM; Pompeo F; Gagliardo C; Merendino AM; Gjomarkaj M
J Allergy Clin Immunol; 2011 Sep; 128(3):635-45.e1-2. PubMed ID: 21571356
[TBL] [Abstract][Full Text] [Related]
10. Lauroside B, a megastigmane glycoside from Laurus nobilis (bay laurel) leaves, induces apoptosis in human melanoma cell lines by inhibiting NF-κB activation.
Panza E; Tersigni M; Iorizzi M; Zollo F; De Marino S; Festa C; Napolitano M; Castello G; Ialenti A; Ianaro A
J Nat Prod; 2011 Feb; 74(2):228-33. PubMed ID: 21188975
[TBL] [Abstract][Full Text] [Related]
11. The small-molecule inhibitor selectivity between IKKα and IKKβ kinases in NF-κB signaling pathway.
Tian F; Zhou P; Kang W; Luo L; Fan X; Yan J; Liang H
J Recept Signal Transduct Res; 2015; 35(4):307-18. PubMed ID: 25386663
[TBL] [Abstract][Full Text] [Related]
12. MLN120B, a novel IkappaB kinase beta inhibitor, blocks multiple myeloma cell growth in vitro and in vivo.
Hideshima T; Neri P; Tassone P; Yasui H; Ishitsuka K; Raje N; Chauhan D; Podar K; Mitsiades C; Dang L; Munshi N; Richardson P; Schenkein D; Anderson KC
Clin Cancer Res; 2006 Oct; 12(19):5887-94. PubMed ID: 17020997
[TBL] [Abstract][Full Text] [Related]
13. The IKKα-dependent non-canonical pathway of NF-κB activation is constitutively active and modulates progression-related functions in a subset of human melanomas.
Dewert N; Amschler K; Lorenz V; Schön MP
Arch Dermatol Res; 2016 Dec; 308(10):733-742. PubMed ID: 27744496
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of inflammatory cytokine production from rheumatoid synovial fibroblasts by a novel IkappaB kinase inhibitor.
Tsuchiya A; Imai K; Asamitsu K; Waguri-Nagaya Y; Otsuka T; Okamoto T
J Pharmacol Exp Ther; 2010 Apr; 333(1):236-43. PubMed ID: 20053934
[TBL] [Abstract][Full Text] [Related]
15. Compensatory IKKalpha activation of classical NF-kappaB signaling during IKKbeta inhibition identified by an RNA interference sensitization screen.
Lam LT; Davis RE; Ngo VN; Lenz G; Wright G; Xu W; Zhao H; Yu X; Dang L; Staudt LM
Proc Natl Acad Sci U S A; 2008 Dec; 105(52):20798-803. PubMed ID: 19104039
[TBL] [Abstract][Full Text] [Related]
16. Activation of the NF-kappaB pathway by the leukemogenic TEL-Jak2 and TEL-Abl fusion proteins leads to the accumulation of antiapoptotic IAP proteins and involves IKKalpha.
Malinge S; Monni R; Bernard O; Penard-Lacronique V
Oncogene; 2006 Jun; 25(25):3589-97. PubMed ID: 16434962
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of NF-kappaB activation in a H4IIE transfectant insensitive to doxorubicin-induced apoptosis.
Chovolou Y; Wätjen W; Kampkötter A; Kahl R
Toxicology; 2007 Mar; 232(1-2):89-98. PubMed ID: 17223244
[TBL] [Abstract][Full Text] [Related]
18. Induction of apoptosis in estrogen receptor-negative breast cancer cells by natural and synthetic cyclopentenones: role of the IkappaB kinase/nuclear factor-kappaB pathway.
Ciucci A; Gianferretti P; Piva R; Guyot T; Snape TJ; Roberts SM; Santoro MG
Mol Pharmacol; 2006 Nov; 70(5):1812-21. PubMed ID: 16908599
[TBL] [Abstract][Full Text] [Related]
19. Chemosensitization of tumor cells: inactivation of nuclear factor-kappa B associated with chemosensitivity in melanoma cells after combination treatment with E2F-1 and doxorubicin.
Hao H; Zhou HS; McMasters KM
Methods Mol Biol; 2009; 542():301-13. PubMed ID: 19565909
[TBL] [Abstract][Full Text] [Related]
20. Cell-selective inhibition of NF-κB signaling improves therapeutic index in a melanoma chemotherapy model.
Enzler T; Sano Y; Choo MK; Cottam HB; Karin M; Tsao H; Park JM
Cancer Discov; 2011 Nov; 1(6):496-507. PubMed ID: 22389871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
